Assignee profile:

TECHLAB, INC.

City:

BLACKSBURG, Virginia

Country:

United States

Published Applications:

18

Last publication date:

2017-06-15

Patent Grants:

16

Last grant date:

2019-02-05

Top Inventors for applications by TECHLAB, INC.

These are the the leading inventors for applications assigned to TECHLAB, INC.:

Recent patent applications by TECHLAB, INC.

TECHLAB, INC. based in BLACKSBURG, US has been assigned the rights to these inventions. The list includes both Pending Applications and Patent Grants:

#1 | 2017-06-15 ✅ Patent 10,196,632 granted on 2019-02-05
US20170166885A1
Chemistry; metallurgy

Nucleic acid extraction using organic solvents to remove inhibitors

#2 | 2016-05-19 ✅ Patent 9,528,105 granted on 2016-12-27
US20160138009A1
Chemistry; metallurgy

Nucleic acid extraction using organic solvents to remove inhibitors

#3 | 2015-02-12 ✅ Patent 9,470,684 granted on 2016-10-18
US20150044697A1
Physics

Outer membrane protein 18 as a diagnostic marker for campylobacter

#4 | 2014-08-07 ✅ Patent 10,295,536 granted on 2019-05-21
US20140219966A1
Physics

Fecal lactoferrin as a biomarker for determining disease severity and for treating infection in patients with disease

#5 | 2013-11-14 ✅ Patent 9,133,527 granted on 2015-09-15
US20130302813A1
Chemistry; metallurgy

Cell wall protein CwpV (CD0514) as a diagnostic marker for ribotype 027

#6 | 2013-10-17 ✅ Patent 9,274,112 granted on 2016-03-01
US20130273642A1
Physics

Device and method for detection of analytes

#7 | 2013-05-23 ✅ Patent 8,790,880 granted on 2014-07-29
US20130130281A1
Physics

Cysteine protease Cwp84 (CD2787) as a diagnostic marker for

#8 | 2013-02-28 ✅ Patent 10,295,535 granted on 2019-05-21
US20130052640A1
Physics

Clostridium difficile dehydrogenase and toxin as a biomarker for monitoring infection in patients with clostridium difficile disease and differentiating carrier state from active disease

#9 | 2012-11-01
US20120276060A1
Physics

FECAL LACTOFERRIN AS A BIOMARKER FOR DETERMINING DISEASE SEVERITY AND FOR TREATING INFECTION IN PATIENTS WITH CLOSTRIDIUM DIFFICILE DISEASE

#10 | 2012-11-01
US20120276059A1
Physics

FECAL LACTOFERRIN AS A BIOMARKER FOR DETERMINING DISEASE SEVERITY AND FOR MONITORING INFECTION IN PATIENTS WITH CLOSTRIDIUM DIFFICILE DISEASE

#11 | 2011-12-29 ✅ Patent 8,541,242 granted on 2013-09-24
US20110318240A1
Physics

Device and method for detection of analytes

#12 | 2010-08-31 ✅ Patent 7,785,818 granted on 2010-08-31
US10693377
-

Inflammatory bowel disease and irritable bowel syndrome IBD-first chek diagnostic panel

#13 | 2010-06-15 ✅ Patent 7,736,858 granted on 2010-06-15
US10656034
-

Method for distinguishing ulcerative colitis from Crohn's disease by detecting the presence of fecal anit-neutrophil cytoplasmic antibodies (ANCA)

#14 | 2009-10-08 ✅ Patent 7,892,762 granted on 2011-02-22
US20090253155A1
Physics

Method for diagnosing irritable bowel syndrome and monitoring inflammatory bowel disease

#15 | 2009-07-14 ✅ Patent 7,560,240 granted on 2009-07-14
US10629975
-

Method for monitoring gastrointestinal inflammation in persons with inflammatory bowel disease(IBD)

#16 | 2007-03-20 ✅ Patent 7,192,724 granted on 2007-03-20
US10002842
-

Method for differentiating irritable bowel syndrome from inflammatory bowel disease (IBD) and for monitoring persons with IBD using total endogenous lactoferrin as a marker

#17 | 2005-09-06 ✅ Patent 6,939,548 granted on 2005-09-06
US10222038
-

Methods to produce high levels of C. difficile toxins

#18 | 2005-03-29 ✅ Patent 6,872,540 granted on 2005-03-29
US10280564
-

Method and apparatus for distinguishing Crohn's disease from ulcerative colitis and other gastrointestinal diseases by detecting the presence of fecal antibodies to Saccharomyces cerevisiae

Also check out Techlab, Inc.'s (Blacksburg, United States) applicant profile with 8 patent applications submitted.

AssigneeID:

11621 ⎘